USING MICROEMULSION FORMULATIONS FOR ORAL-DRUG DELIVERY OF THERAPEUTIC PEPTIDES

被引:124
作者
SARCIAUX, JM [1 ]
ACAR, L [1 ]
SADO, PA [1 ]
机构
[1] UNIV RENNES 1, FAC SCI BIOL & PHARMACEUT, BIOPHARM & PHARM CLIN, PHARM GALEN LAB, RENNES, FRANCE
关键词
PEPTIDE; MICROEMULSION; ORAL DRUG DELIVERY;
D O I
10.1016/0378-5173(94)00386-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peptide drugs are increasingly becoming a very important class of therapeutic agents with the rapid advances in the field of biotechnology engineering. However, these drugs are generally not suitable for oral administration. In this review, the main physico-chemical and biopharmaceutical characteristics of peptides are summarized. The obstacles to peptide drug absorption and the different possibilities for solving these difficulties are listed. Results using this formulation approach for oral drug delivery of peptides are apparently promising with some specific peptides such as cyclosporin. Various mechanisms are only beginning to be understood and further investigations need to be performed in this area to explain the results obtained with some peptides.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 59 条
[31]  
LEE VHL, 1991, PEPTIDE PROTEIN DRUG, P691
[32]  
LEE WHL, 1986, PHARM INT, P208
[33]   NOVEL ORAL MICROSPHERES OF INSULIN WITH PROTEASE INHIBITOR PROTECTING FROM ENZYMATIC DEGRADATION [J].
MORISHITA, M ;
MORISHITA, I ;
TAKAYAMA, K ;
MACHIDA, Y ;
NAGAI, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 78 (01) :1-7
[34]  
MUELLER E, 1993, 6TH C EUR SOC ORG TR, P131
[35]   INFLUENCE OF A FAT-RICH MEAL ON THE PHARMACOKINETICS OF A NEW ORAL FORMULATION OF CYCLOSPORINE IN A CROSSOVER COMPARISON WITH THE MARKET FORMULATIONS [J].
MUELLER, EA ;
KOVARIK, JM ;
VANBREE, JB ;
GREVEL, J ;
LUCKER, PW ;
KUTZ, K .
PHARMACEUTICAL RESEARCH, 1994, 11 (01) :151-155
[36]   FACTORS AFFECTING THE LYMPHATIC TRANSPORT OF PENCLOMEDINE (NSC-338720), A LIPOPHILIC CYTOTOXIC DRUG - COMPARISON TO DDT AND HEXACHLOROBENZENE [J].
MYERS, RA ;
STELLA, VJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 80 (01) :51-62
[37]   THE EFFECT OF ADDITIVES ON THE ORAL MUCOSAL ABSORPTION OF HUMAN CALCITONIN IN RATS [J].
NAKADA, Y ;
AWATA, N ;
NAKAMICHI, C ;
SUGIMOTO, I .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1988, 11 (06) :395-401
[38]   CLINICAL PHARMACOKINETICS OF CYCLOSPORINE [J].
PTACHCINSKI, RJ ;
VENKATARAMANAN, R ;
BURCKART, GJ .
CLINICAL PHARMACOKINETICS, 1986, 11 (02) :107-132
[39]  
RICO I, 1986, ENTRETIENS CARLA, V7, P77
[40]  
RITSCHEL WA, 1991, METHOD FIND EXP CLIN, V13, P205